Canagliflozin vs Ipilimumab

## Canagliflozin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Ipilimumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Ipilimumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Ipilimumab — N/A.

**Type**: Canagliflozin — Small molecule; Ipilimumab — Antibody.